LATISHA HUDSON: Open Payments
NPI 1275172785 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 36 payments from 6 companies in 2025. Trend: 2023 $685 · 2024 $611 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 13 | $329 |
| Neurocrine BioSciences, Inc. | 17 | $203 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $13 |
Products named: INGREZZA, ARISTADA, LYBALVI, COBENFY, INVEGA SUSTENNA, HETLIOZ, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
